Study links heart-surgery drug to major health risks - Health & Science - International Herald Tribune

Study links heart-surgery drug to major health risks - Health & Science - International Herald Tribune: "The drug is aprotinin, made by Bayer and sold under the brand name Trasylol. It has been on the market for 13 years. Halting its use globally would prevent 10,000 to 11,000 cases of kidney failure a year, and save more than $1 billion a year in dialysis costs as well as nearly $250 million spent on the drug itself, according to a report to be published Thursday in The New England Journal of Medicine."

My Thoughts: I once describes just such a situation when I said, "Perhaps if we truly knew the complete biological chemistry we would see that one factory making a products is polluting the environment for which we will produce a solution. Perhaps in another factory that produces another pollution that creates a second disease while curing the first."